semaglutide going off the market Weight loss patients fret over FDA limits on off-brand drugs is semaglutide being taken off

Adult candidates should have a BMI greater than 30 or a BMI of 27 or higher with one or more weight-related medical problems

Therefore, it is advised that patients asking the question Should I switch from semaglutide to tirzepatide? are aware and informed that research about the long-term effects of the drug is still ongoing

This measured approach stands in contrast to the all-or-nothing thinking that can derail long-term adherence

honoraria from Novo Nordisk, AstraZeneca, Bayer, Fresenius and Novartis

By contrast, trials of common soluble fibersglucomannan, psyllium husk, inulin and resistant dextrintend to show modest, often inconsistent weight effects